Biomarkers 2014

Overview

SELECTBIO, working together with Andreas Jeromin are pleased to announce their joint collaboration: Biomarkers in CNS Drug Discovery and Development: From Discovery to Clinical Diagnostics.

This meeting will highlight current advances in the use of biomarkers in the context of CNS drug discovery and development and highlight strategies for their translation from discovery tolls to clinical diagnostics. This is embedded into the discussion of innovate technologies for biomarker development, their non-clinical use, clinical development and regulatory strategies and serve as a unique forum for networking, critical assessment based on presented case studies and panel discussions. It will bring together a group of international experts across academy and industry across a spectrum of CNS disorders, ranging from neurodegenerative, neuropsychiatric, neurodevelopmental to neurological disorders.